Advantage Investment Management’s Immunogen Inc IMGN Stock Holding History

Advantage Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-500	Closed	-$5K	–	1052
2018 Q1	$5K	Hold	500	–	–	﹤0.01%	814
2017 Q4	$3K	Hold	500	–	–	﹤0.01%	898
2017 Q3	$4K	Hold	500	–	–	﹤0.01%	870
2017 Q2	$4K	Hold	500	–	–	﹤0.01%	884
2017 Q1	$2K	Hold	500	–	–	﹤0.01%	920
2016 Q4	$1K	Hold	500	–	–	﹤0.01%	933
2016 Q3	$1K	Hold	500	–	–	﹤0.01%	894
2016 Q2	$2K	Hold	500	–	–	﹤0.01%	804
2016 Q1	$4K	Hold	500	–	–	﹤0.01%	721
2015 Q4	$7K	Hold	500	–	–	﹤0.01%	642
2015 Q3	$5K	Sell	500 -500	-50%	-$7.31K	﹤0.01%	666
2015 Q2	$14K	Hold	1,000	–	–	0.01%	531
2015 Q1	$9K	Buy	+1,000	New	+$7.24K	0.01%	611

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advantage Investment Management's IMGN Position: Q2 2018 in Review

Advantage Investment Management sold out of Immunogen Inc (IMGN) in Q2 2018, closing a stake of 500 shares — an estimated $5K sold.

Advantage Investment Management first reported a position in IMGN in Q1 2015 and held it in 13 quarters. The position peaked at $14K in Q2 2015. 198 funds tracked by Wall St. Rank hold IMGN as of Q2 2018.

Advantage Investment Management reported no remaining Immunogen Inc position as of Q2 2018 after selling out during the quarter.
Advantage Investment Management sold 500 Immunogen Inc shares in Q2 2018, an estimated $5K.
Advantage Investment Management first reported a position in Immunogen Inc in Q1 2015 and held it in 13 quarters.
Advantage Investment Management's Immunogen Inc position peaked at $14K in Q2 2015.
198 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2018.

Based on Advantage Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.